Position in PCRX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$7,922,974
-$1,179,515 QoQ
Shares Held
312,297
-22.5% QoQ
Ownership
0.783%
of shares outstanding
% of Portfolio
1.83%
of 13F equity value
Holder Rank
#28
of 253 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridge City Capital, LLC holds $24,367,503 across 5 Drug Manufacturers - Specialty & Generic names. PCRX ranks #1 (32.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PCRX |
Pacira BioSciences, Inc.
This page
|
312,297 | $7,922,974 | |
| 2 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
338,708 | $6,835,127 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
78,167 | $3,635,547 | |
| 4 | ETON |
Eton Pharmaceuticals, Inc.
|
88,132 | $3,190,378 | |
| 5 | ANIP |
Ani Pharmaceuticals Inc
|
33,625 | $2,783,477 |
All Filings in PCRX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,922,974 | 312,297 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $9,102,489 | 402,765 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $7,388,558 | 285,493 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,025,911 | 311,444 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,055,184 | 169,673 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,277,828 | 172,146 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $4,318,052 | 229,196 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,479,785 | 231,215 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,427,730 | 84,856 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,810,003 | 61,944 | Shares | Sole | 2024-04-12 | |
| No filing history on record for this holder in this stock. | ||||||